DiagnaMed Holdings Corp. · CSE:DMED
DiagnaMed — Investor Presentation (May 2023)
16 slides from DiagnaMed's investor presentation, May 2023
Slide 1: Generative AI Healthcare Solutions Corporate Presentation
Generative AI Corporate Presentation Healthcare Solutions May 2023 DiagnaMed Holdings Corp. 82 Richmond Street East Toronto, ON M5C 1P1 e. info@diagnamed.com t. 416-800-2684
Slide 2: Forward-Looking Statements
This presentation of DiagnaMed Holdings Corp. (“DiagnaMed”) contains "forward- looking information", which may include, but is not limited to, statements with respect to anticipated business plans or strategies of DiagnaMed, the anticipated date of completion of product developments, the timing of a
Slide 3: Commercializing Generative AI Healthcare Solutions
Commercializing Generative AI Healthcare Solutions Our Platforms CERVAI™ HEALTH GENAI Generative AI Generative AI Brain Health Platform Healthcare Applications CSE: DMED | OTCQB: DGNMF
Slide 4: CERVAI Generative AI Brain Health Platform
CERVAI™ Generative AI Brain Health Platform CSE: DMED | OTCQB: DGNMF
Slide 5: Digital Brain Health Market
+1 Billion Digital Brain Mental Health Depression, PTSD, Anxiety, etc Health Market over $375 Billion +1 Billon by 2031* Neurodegenerative Parkinson's, Alzheimer's, Brain injury, Dementia, *Source: TMR Report https://www.prnewswire.com/news- releases/digital-brain-health-market-to-exceed-value-of- C
Slide 6: Problem
Problem I have a family history of Alzheimer's There is no one-fits-all solution I'm feeling depressed for estimating, monitoring and I keep on forgetting things improving brain health. Expensive equipment and unproven intervention methods must be more reliable and scalable. CSE: DMED | OTCQB: DGNMF
Slide 7: Solution CERVAI
Solution Brain Age Brain Health Estimation Score Use of a novel Evaluate overall brain electroencephalogram health, output a patient (EEG) device and ML/AI risk score, and provide technique for predicting actionable data powered and monitoring brain age. by GPT. Brain Health CERVAI™ Brain Disorder G
Slide 8: CERVAI Journey
CERVAI™ Journey 1 How old is my brain? 2 3 1 2 3 TAKING CONTROL ESTIMATING BRAIN AGE BRAIN HEALTH REPORT Curious, depressed, neuro disorder, Schedule a visit to a CERVAI™ Report with estimated brain age family history, provider and brain health assessment 4 5 6 5 5 NEXT STEPS FOR BRAIN HEALTH EARLY
Slide 9: Business Model CERVAI
Business Model License Fees Place in up to 25,000 provider locations in North America (Primary care physicians, psychiatric & neurology clinics, senior care homes, pharmacies) Recurring Visits Patient programs offered 2-12 visits per year App Subscriptions Monthly subscription to virtual clinic digi
Slide 10: Commercial Pathway
Commercial Pathway 2024 H2-2023 H1-2023 Unlock new uses of CERVAI™ Commercialize Clinical diagnostic tool for CERVAI™ monitoring and screening of mental health, neurological and Grow provider sites, consumer brain injuries Establish CERVAI™ provider and patient awareness network Licensed physicians
Slide 11: Partnerships
Partnerships Brain Age Brain Health Development Development CSE: DMED | OTCQB: DGNMF
Slide 12: HEALTH GENAI
HEALTH GENAI Generative AI Healthcare Applications CSE: DMED | OTCQB: DGNMF
Slide 13: Generative AI in the healthcare market to reach
Generative AI in the healthcare market to reach ~ USD 17 billion by 2032* *Source: Market.us https://www.globenewswire.com/news- release/2023/04/03/2639957/0/en/Generative-AI-in- Healthcare-Market-Set-to-Reach-a-Valuation-of-USD-17-2- CSE: DMED | OTCQB: DGNMF Bn-by-2032-Data-Analysis-by-Experts-at-M
Slide 14: Leveraging our experience in building generative AI
Leveraging our experience in building generative AI HEALTH GENAI Generative AI applications to Healthcare Applications complement CERVAI™ Launched In-development and the unmet needs FORM GPT Dr. GENAI of the healthcare Healthcare providers to create forms powered by ChatGPT Enabling patients and pra
Slide 15: Team
Team Management & Advisors Board of Directors Fabio Chianelli Fabio Chianelli Chairman, CEO ,Chairman, CEO Founder, CEO - PharmaTher Founder, CEO - PharmaTher Founder, President - Revive Therapeutics Founder, President - Revive Therapeutics Dr. Bassma Ghali, PhD Ming Jang, CPA, CGA VP, Product Chief
Slide 16: Capital Structure
80,052,640 ~ 21% Capital Common Shares outstanding Insider Ownership Structure 2,000,000 Stock Options 240,000 Warrants $0.10 expires June 18, 2023 37,382,226 Common Shares are subject to escrow 1/10th released at: November 8, 2023, 2024, 2025 May 8, 2024, 2025, 2026 2/10th released at: November 8,
DiagnaMed Holdings — Investor Presentation (May 2023) on 6ix